Disease: Schizotaxia
- "Schizotaxia": clinical implications and new directions for research
- A review of neuroimaging studies of young relatives of individuals with schizophrenia: a developmental perspective from schizotaxia to schizophrenia
- An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention
- Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study
- Carving nature at its joints: Paul Meehl's development of taxometrics
- Children at risk for schizophrenia: the Jerusalem Infant Development Study. II. Neurobehavioral deficits at school age
- Conceptualization of the liability for schizophrenia: clinical implications
- Concurrent validation of schizotaxia: a pilot study
- Developing a combined predictor measure for early detection of psychosis proneness
- Development of liability syndromes for schizophrenia: where did they come from and where are they going?
- Dimensionality vs taxonicity of schizotypy: some new data and challenges ahead
- Discerning the latent structure of hypothetical psychosis proneness through admixture analysis
- Early diagnosis of schizophrenic psychosis
- Generalized cognitive impairment in male adolescents with schizotypal personality disorder
- Genes, environment and schizophrenia
- Genetic markers for schizotaxia
- Long-term administration of the low-dose risperidone in schizotaxia subjects
- Minor physical anomalies and schizophrenia: literature review
- Moderately Eccentric: Evidence for Dimensionality in the Latent Structure of Schizotypal Personality Features
- Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia
- Pathways from developmental vulnerabilities in early childhood to schizotypy in middle childhood
- Prediction of Neurocognitive Deficits by Parkinsonian Motor Impairment in Schizophrenia: A Study in Neuroleptic-Naïve Subjects, Unaffected First-Degree Relatives and Healthy Controls From an Indigenous Population
- Prevention of schizophrenia
- Schizophrenia: family studies and treatment of spectrum disorders
- Schizophrenia: vulnerability versus disease
- Schizotaxia revisited
- Schizotaxia revisited: model issues in the etiology of schizophrenia
- Schizotaxia--theoretical construct or a tool for clinical research?
- Schizotaxia, information processing and the MMPI 2-7-8 code type
- Schizotaxia, schizotypy, and schizophrenia: Paul E. Meehl's blueprint for the experimental psychopathology and genetics of schizophrenia
- Schizotaxia: current status and future directions
- Searching for the liability to schizophrenia: concepts and methods underlying genetic high-risk studies of adolescents
- Self-centrality, psychosis and schizotaxia: a conceptual review
- Subjective experience of schizotropic vulnerability in siblings of schizophrenics
- The genetic and environmental basis of the relationship between schizotypy and personality: a twin study
- The genetics of schizophrenia
- The latent structure and coincidence of hypohedonia and schizotypy and their validity as indices of psychometric risk for schizophrenia
- The silent side of the spectrum: schizotypy and the schizotaxic self
- Thought disorder in offspring of schizophrenic parents: findings from the New York High-Risk Project
- Toward reformulating the diagnosis of schizophrenia
- Towards the prevention of schizophrenia
- Understanding predisposition to schizophrenia: toward intervention and prevention
- Validating schizotaxia and its place in studies of preventing schizophrenia by psychopharmacological intervention